Parvalis Therapeutics Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
Parvalis Therapeutics General Information
Description
Operator of a biotechnology company intended to develop novel immunotherapeutics for autoimmune disorders. The company offers autoimmune therapies and also conducts research in the development of novel immunomodulatory compounds, enabling patients and doctors to access treatments for inflammatory diseases and cancer.
Contact Information
Website
www.parvalistx.comCorporate Office
- 6th Floor South Bank House
- Barrow Street
- Dublin
- Ireland
Corporate Office
- 6th Floor South Bank House
- Barrow Street
- Dublin
- Ireland
Parvalis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 06-May-2026 | Completed | Out of Business | |||
| 2. Early Stage VC | 17-Apr-2023 | Completed | Startup | |||
| 1. Early Stage VC | 01-Jan-2021 | Completed | Startup |
Parvalis Therapeutics Signals
Parvalis Therapeutics FAQs
-
When was Parvalis Therapeutics founded?
Parvalis Therapeutics was founded in 2020.
-
Where is Parvalis Therapeutics headquartered?
Parvalis Therapeutics is headquartered in Dublin, Ireland.
-
What is the size of Parvalis Therapeutics?
Parvalis Therapeutics has 2 total employees.
-
What industry is Parvalis Therapeutics in?
Parvalis Therapeutics’s primary industry is Biotechnology.
-
Is Parvalis Therapeutics a private or public company?
Parvalis Therapeutics is a Private company.
-
What is Parvalis Therapeutics’s current revenue?
The current revenue for Parvalis Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process